Described herein are compounds and pharmaceutical compositions containing such compounds, which inhibit the activity of Olig2. Also described herein are methods of using such Olig2 inhibitors, alone and in combination with other compounds, for treating ca
-
Paragraph 00419-00420
(2017/04/19)
Synthesis and structure activity relationship of guanidines as NPY Y5 antagonists
A series of bis-aryl substituted guanidines have been discovered as potent NPY Y5 antagonists. The SAR and in vitro metabolic stability of these compounds are discussed.
Aquino, Christopher J.,Ramanjulu, Joshi M.,Heyer, Dennis,Daniels, Alejandro J.,Palazzo, Fabio,Dezube, Milana
p. 2691 - 2708
(2007/10/03)
More Articles about upstream products of 859732-53-9